Orange Book product · Generic (ANDA)
APOMORPHINE HYDROCHLORIDE
APOMORPHINE HYDROCHLORIDE
Generic (ANDA)ANDA 212025TE APRX TP ANDA HOLDINGS
At a glance
Feb 23, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 23, 2022
4 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
APOMORPHINE HYDROCHLORIDE
Strength
30MG/3ML (10MG/ML)
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
TE code
AP
Application
ANDA 212025
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of APOMORPHINE HYDROCHLORIDE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
